BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18044265)

  • 21. Rituximab in refractory Wegener's granulomatosis: Favorable or not?
    Aries PM; Lamprecht P; Gross WL
    Am J Respir Crit Care Med; 2006 Apr; 173(7):815-6; author reply 816. PubMed ID: 16556703
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
    Bachmeyer C; Cadranel JF; Demontis R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1274. PubMed ID: 15840659
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab.
    Sharma A; Kumar S; Wanchu A; Lal V; Singh R; Gupta V; Singh S; Gupta A
    Clin Rheumatol; 2010 Jan; 29(1):107-10. PubMed ID: 19802640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
    Haubitz M; Koch KM; Brunkhorst R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1713-8. PubMed ID: 9681717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.
    Ferraro AJ; Smith SW; Neil D; Savage CO
    Nephrol Dial Transplant; 2008 Sep; 23(9):3030-2. PubMed ID: 18586761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of Wegener's granulomatosis 13 years after renal transplantation.
    Fan SL; Lewis KE; Ball E; Dodd S; Raftery MJ; Yaqoob MM
    Am J Kidney Dis; 2001 Dec; 38(6):E32. PubMed ID: 11728992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C
    Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal & ocular targets for therapy in Wegener's granulomatosis.
    Joshi L; Hamour S; Salama AD; Pusey CD; Lightman S; Taylor SR
    Inflamm Allergy Drug Targets; 2009 Mar; 8(1):70-9. PubMed ID: 19275695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN; Woronik V; Halpern AS; Barbas CS
    J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory Wegener's granulomatosis presenting with alveolar haemorrhage, treated with rituximab.
    Caetano J; Fernandes das Neves M; Oliveira S; Delgado Alves J
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519869
    [No Abstract]   [Full Text] [Related]  

  • 32. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
    de Menthon M; Cohen P; Pagnoux C; Buchler M; Sibilia J; Détrée F; Gayraud M; Khellaf M; Penalba C; Legallicier B; Mouthon L; Guillevin L
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintaining remission in a patient with vasculitis.
    Flossmann O; Jayne DR
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):499-504. PubMed ID: 18648340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
    Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
    Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Wegener's granulomatosis--diagnostic problem].
    Durko T; Lapienis M; Jankowski A
    Otolaryngol Pol; 2006; 60(3):355-62. PubMed ID: 16989448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulomatosis with polyangiitis (Wegener's) as a necrotizing gingivitis mimic: a case report.
    Genuis K; Pewarchuk J
    J Med Case Rep; 2014 Sep; 8():297. PubMed ID: 25196320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of granulomatosis with polyangiitis (Wegener's).
    Pagnoux C; Guillevin L
    Expert Rev Clin Immunol; 2015 Mar; 11(3):339-48. PubMed ID: 25644677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide.
    Steinman TI; Jaffe BF; Monaco AP; Wolff SM; Fauci AS
    Am J Med; 1980 Mar; 68(3):458-60. PubMed ID: 6987874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.